Pharmafile Logo

Charles River

For more than 60 years, Charles River has provided tailored research models and laboratory animal support services, as well as preclinical and clinical support services, to help our global partners accelerate their research and drug development efforts. Our offerings span the entire drug development process, from discovery through market approval, forming a seamless partnership throughout the process.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Company Details

Charles River Laboratories International, Inc., 251 Ballardvale Street, Wilmington, MA 01887, USA
+800.3195.3430

 Latest Content from PMHub 

How can the NHS deliver integrated care?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain the changes needed to help the NHS provide a more holistic, joined up experience for patients

A Bitter Pill?

White Papers and Resources | December 14, 2016 | Inizio

The ideal route of admin isn’t clear cut in the global marketplace

2017: Medical education that improves value and outcomes for patients

In December’s Issue of PME, two of Lucid’s senior management team – Shula Sarner and Tanya Goodyear – consider how medical education will evolve in 2017.   They discuss industry...

How can pharma engage with NHS Vanguards?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore the opportunities for pharma to help NHS vanguards develop new models of care.

Webinar: Become your customer’s chosen channel

Your customer now expects to access knowledge in any format and at any time that they desire. But how do you become the ever-present partner that they trust and value...

Understanding the chronic disease patient journey in emerging markets

White Papers and Resources | December 7, 2016 | Inizio

In this paper, we will explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these...

Infographic: Keeping tracking on track

White Papers and Resources | December 7, 2016 | Inizio

Our best practice approach to tracking studies.

Lucid Group kick off their Winter Festival

The start of December not only signalled the official calendar countdown to Christmas, but also marked the official launch of the Lucid Winter Festival, which culminates in the Winter Summit...

What does the Five Year Forward View mean for pharma?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess how the Five Year Forward View (5YFV) is changing the NHS and how pharma can get involved in redesigning NHS services.

Healthcare in the Digital Age

White Papers and Resources | December 3, 2016 | M3 (EU)

Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship.